Ignite Creation Date:
2024-05-06 @ 1:36 AM
Last Modification Date:
2024-10-26 @ 11:06 AM
Study NCT ID:
NCT01852019
Status:
COMPLETED
Last Update Posted:
2015-06-24
First Post:
2013-05-06
Brief Title:
Cangrelor Prasugrel Transition Study
Sponsor:
The Medicines Company
Organization:
The Medicines Company
Study Overview
Official Title:
A Study of the Transition From IV Cangrelor to Oral Prasugrel and Prasugrel to Cangrelor in Patients With Coronary Artery Disease
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To demonstrate that patients treated with cangrelor can be directly switched to oral prasugrel and that patients treated with prasugrel can be switched to cangrelor without a significant decrease in the extent of inhibition of platelet aggregation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None